Skip to content
Discover expert reviews, racing tips, and performance insig…

Users Coming Off Slimming Jabs Gain Back Weight Far More Rapidly Than Dieters

Image of medical syringe and weighing machine
Weight management often requires ongoing approaches.

Fresh analysis suggests that patients who stop using popular weight-loss injections like Mounjaro or Wegovy can put back on lost weight at a significantly accelerated pace than those who stop traditional diet and exercise programs.

Research printed in a prominent health publication points out that while obese people often shed a large proportion of their total mass while using the jabs, the weight is regained at an average rate of 0.8 kg per month once they quit.

"Users purchasing such drugs need to be informed of the potential of fast rebound weight gain when the medication concludes," stated expert Dr. Susan Jebb.

This pace of regain implies a return to starting mass within about 18 months.

Weighing Approaches

The research, which reviewed dozens of trials involving over 9,000 of participants, contrasted the outcomes of these new drugs with older methods.

Scientists emphasize that people who shed pounds through lifestyle changes alone typically have a more gradual creep back—approximately 100 grams monthly—once they finish.

Understanding the Rapid Rebound

Nutrition scientists propose the mode of action of the jabs explains the heightened weight return.

These medications imitate a body's own chemical called GLP-1, which moderates feelings of fullness.

"Sustained high doses of GLP-1 levels several times higher than normal could lead to the body to produce less of its own natural hormone, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.

"Stopping of this hormone supplement means hunger is unsuppressed, making excessive eating a significant risk."

A Lifelong Issue?

The NHS suggest the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.

Many experts say that, considering the likelihood of weight regain, the treatment should be considered life-long.

This view is echoed by drug manufacturers, who note that the findings "underscore the long-term nature of obesity," akin to managing conditions like high blood pressure.

User Experiences

Individuals who have discontinued the medication describe a powerful return of appetite.

"I experienced a trigger that goes on and you become extremely hungry," said one woman.

This difficulty is compounded if patients have not developed permanent lifestyle or habit modifications during treatment.

Significant Use

Recent estimates show that millions of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.

  • Use is greater among women compared to men.
  • The 40s and 50s demographic shows the greatest level of interest.
  • A large proportion obtain the medications through private prescriptions rather than the NHS.

In conclusion, clinicians emphasize that while these medications are effective tools for shedding pounds, they are not a magic fix and maintained weight loss likely depends on integrated lifestyle changes.

AW
Written by

Alicia Wright

A motorsport journalist with over a decade of experience covering Formula 1 and high-performance vehicles.

Velocity Palace

Type to search articles.